Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Tybjaerg-Hansen

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Blood|June 19, 2002
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analysesKlaus Juul, Anne Tybjaerg-Hansen, Rolf Steffensen, et al.
Archives of Internal Medicine|September 28, 2005
Factor V leiden homozygosity, dyspnea, and reduced pulmonary functionKlaus Juul, Anne Tybjaerg-Hansen, Jann Mortensen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2007
Genetic variation in ABCA1 predicts ischemic heart disease in the general populationRuth Frikke-Schmidt, Børge G Nordestgaard, Gorm B Jensen, et al.
Genetic Epidemiology|November 26, 2008
Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart diseaseGreg Dyson, Ruth Frikke-Schmidt, Børge G Nordestgaard, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2006
Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart StudyHans H Wittrup, Rolf V Andersen, Anne Tybjaerg-Hansen, et al.
The New England Journal of Medicine|October 31, 2008
Genetically elevated C-reactive protein and ischemic vascular diseaseJeppe Zacho, Anne Tybjaerg-Hansen, Jan Skov Jensen, et al.
Annals of Neurology|February 22, 2011
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general populationAnette Varbo, Børge G Nordestgaard, Anne Tybjaerg-Hansen, et al.
American Journal of Respiratory and Critical Care Medicine|October 21, 2006
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseMorten Dahl, Jørgen Vestbo, Peter Lange, et al.
Ugeskrift for Laeger|October 17, 2002
[Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population]Lisbeth Enggaard Larsen, Christina Ellervik, Merete Appleyard, et al.
The Journal of Biological Chemistry|March 31, 2005
Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptorMarianne Benn, Børge G Nordestgaard, Jan Skov Jensen, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Blood|June 19, 2002
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analysesKlaus Juul, Anne Tybjaerg-Hansen, Rolf Steffensen, et al.
Archives of Internal Medicine|September 28, 2005
Factor V leiden homozygosity, dyspnea, and reduced pulmonary functionKlaus Juul, Anne Tybjaerg-Hansen, Jann Mortensen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2007
Genetic variation in ABCA1 predicts ischemic heart disease in the general populationRuth Frikke-Schmidt, Børge G Nordestgaard, Gorm B Jensen, et al.
Genetic Epidemiology|November 26, 2008
Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart diseaseGreg Dyson, Ruth Frikke-Schmidt, Børge G Nordestgaard, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2006
Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart StudyHans H Wittrup, Rolf V Andersen, Anne Tybjaerg-Hansen, et al.
The New England Journal of Medicine|October 31, 2008
Genetically elevated C-reactive protein and ischemic vascular diseaseJeppe Zacho, Anne Tybjaerg-Hansen, Jan Skov Jensen, et al.
Annals of Neurology|February 22, 2011
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general populationAnette Varbo, Børge G Nordestgaard, Anne Tybjaerg-Hansen, et al.
American Journal of Respiratory and Critical Care Medicine|October 21, 2006
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseMorten Dahl, Jørgen Vestbo, Peter Lange, et al.
Ugeskrift for Laeger|October 17, 2002
[Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population]Lisbeth Enggaard Larsen, Christina Ellervik, Merete Appleyard, et al.
The Journal of Biological Chemistry|March 31, 2005
Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptorMarianne Benn, Børge G Nordestgaard, Jan Skov Jensen, et al.
Pageof 15